Skip to main content
OpenTrials

Clinical trial condition

Cystic Fibrosis

Explore clinical trials studying Cystic Fibrosis. Study availability and eligibility vary by location and protocol.

1,229 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Cystic Fibrosis trial results

Completed

A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo

NCT00918957

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Novartis Investigative Site Pleven, Bulgaria
  • Novartis Investigative Site Plovdiv, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Varna, Bulgaria
View all 24 locations
View Trial Details
Completed

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation

NCT00909727

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +8 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Emory Cystic Fibrosis Center Atlanta, Georgia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
  • The Cystic Fibrosis Center of Chicago Glenview, Illinois, United States
View all 29 locations
View Trial Details
Completed

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis

NCT00757848

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Research Site Copenhagen, Denmark
  • Research Site Hamburg, Germany
  • Research Site Kiel, Germany
  • Research Site Leipzig, Germany
View all 14 locations
View Trial Details
Completed

Clinical Evaluation of NeoPlex4 Assay and NeoPlex System

NCT01488721

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +29 more
Locations
  • New York State Department of Health Albany, New York, United States
  • Tennessee Department of Health Nashville, Tennessee, United States
  • Unified State Laboratories: Public Health Taylorsville, Utah, United States
View Trial Details
Completed

Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

NCT00388505

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Novartis Investigative Site Hartford, Connecticut, United States
  • Emory University CF Center Atlanta, Georgia, United States
  • Rush University Center Chicago, Illinois, United States
  • University of Louisville Louisville, Kentucky, United States
View all 72 locations
View Trial Details
Completed

Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients

NCT00506688

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Charité Campus Virchow Klinikum,Klinik für Pädiatrie Berlin, Germany
  • Universitätskinderklinink Bochum, Germany
  • Uniklinik Köln Mukoviszidose Zentrum Cologne, Germany
  • Ruhrlandklinink Essen, Germany
View all 14 locations
View Trial Details

Related conditions